Pedram Argani
Pedram Argani
Professor of Pathology and Oncology, Johns Hopkins University
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
RA Gupta, N Shah, KC Wang, J Kim, HM Horlings, DJ Wong, MC Tsai, ...
Nature 464 (7291), 1071-1076, 2010
43602010
Molecular definition of breast tumor heterogeneity
M Shipitsin, LL Campbell, P Argani, S Weremowicz, N Bloushtain-Qimron, ...
Cancer cell 11 (3), 259-273, 2007
14712007
The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia
JR Srigley, B Delahunt, JN Eble, L Egevad, JI Epstein, D Grignon, O Hes, ...
The American journal of surgical pathology 37 (10), 1469-1489, 2013
9032013
The PIK3CA gene is mutated with high frequency in human breast cancers
KE Bachman, P Argani, Y Samuels, N Silliman, J Ptak, S Szabo, ...
Cancer biology & therapy 3 (8), 772-775, 2004
7622004
Notch mediates TGFα-induced changes in epithelial differentiation during pancreatic tumorigenesis
Y Miyamoto, A Maitra, B Ghosh, U Zechner, P Argani, ...
Cancer cell 3 (6), 565-576, 2003
7372003
Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression
RE Wilentz, CA Iacobuzio-Donahue, P Argani, DM McCarthy, JL Parsons, ...
Cancer research 60 (7), 2002-2006, 2000
6902000
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene …
P Argani, C Iacobuzio-Donahue, B Ryu, C Rosty, M Goggins, RE Wilentz, ...
Clinical cancer research 7 (12), 3862-3868, 2001
5842001
Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and …
P Argani, CR Antonescu, PB Illei, MY Lui, CF Timmons, R Newbury, ...
The American journal of pathology 159 (1), 179-192, 2001
5672001
Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay
P Argani, P Lal, B Hutchinson, MY Lui, VE Reuter, M Ladanyi
The American journal of surgical pathology 27 (6), 750-761, 2003
5522003
Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast
SL Kominsky, P Argani, D Korz, E Evron, V Raman, E Garrett, A Rein, ...
Oncogene 22 (13), 2021-2033, 2003
5332003
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
E De Alava, A Kawai, JH Healey, I Fligman, PA Meyers, AG Huvos, ...
Journal of Clinical Oncology 16 (4), 1248-1255, 1998
5241998
The der (17) t (X; 17)(p11; q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25
M Ladanyi, MY Lui, CR Antonescu, A Krause-Boehm, A Meindl, P Argani, ...
Oncogene 20 (1), 48-57, 2001
5022001
Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray
A Maitra, NV Adsay, P Argani, C Iacobuzio-Donahue, A De Marzo, ...
Modern Pathology 16 (9), 902-912, 2003
4412003
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
Y Jiao, TM Pawlik, RA Anders, FM Selaru, MM Streppel, DJ Lucas, ...
Nature genetics 45 (12), 1470-1473, 2013
4302013
Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum
P Argani, S Olgac, SK Tickoo, M Goldfischer, H Moch, DY Chan, JN Eble, ...
The American journal of surgical pathology 31 (8), 1149-1160, 2007
4042007
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers
MC Haffner, A Chaux, AK Meeker, DM Esopi, J Gerber, LG Pellakuru, ...
Oncotarget 2 (8), 627, 2011
3772011
Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma
P Argani, C Rosty, RE Reiter, RE Wilentz, SR Murugesan, SD Leach, ...
Cancer research 61 (11), 4320-4324, 2001
3592001
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes
CM Heaphy, AP Subhawong, SM Hong, MG Goggins, EA Montgomery, ...
The American journal of pathology 179 (4), 1608-1615, 2011
3482011
Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation
RE Wilentz, GH Su, J Le Dai, AB Sparks, P Argani, TA Sohn, CJ Yeo, ...
The American journal of pathology 156 (1), 37-43, 2000
3452000
Molecular Markers in Ductal Carcinoma in Situ of the Breast1 1 National Cancer Institute Cancer Genome Anatomy Project and Specialized Program in Research Excellence in Breast …
D Porter, J Lahti-Domenici, A Keshaviah, YK Bae, P Argani, J Marks, ...
Molecular Cancer Research 1 (5), 362-375, 2003
3222003
The system can't perform the operation now. Try again later.
Articles 1–20